Skip to main content
Premium Trial:

Request an Annual Quote

BioTrove, Gene Express Awarded NCI Grant to Co-Develop Lung Cancer Risk Dx Platform

NEW YORK (GenomeWeb News) – BioTrove and Gene Express said today that they have been awarded a two-year grant from the National Cancer Institute to develop a genetic profiling test for the risk of lung cancer in collaboration with Mount Sinai School of Medicine.
 
The researchers will combine BioTrove’s OpenArray PCR platform, Gene Express’ PCR standards, and Mount Sinai’s clinical knowledge to study genetic biomarkers linked to lung cancer.
 
Funded through the NCI’s Innovative Technologies for Molecular Analysis of Cancer program, the research will aim to develop a gene expression profiling system called Standardized Nanoarray PCR, or SNAP.
 
The SNAP system will be based on the Gene Express Standardized RT PCR method to control for false negatives and false positives and the BioTrove OpenArray nanofluidic PCR platform, which will “enable large-scale analyses with minimal sample requirements.”
 
According to the companies, the resulting system “will provide the same quality and dynamic range of standard real-time quantitative PCR, but with simplified workflow and reduced sample requirements — an important consideration when dealing with limited clinical samples.”
 
Once the tool is developed, the companies said it will undergo an independent evaluation at the Harvard University School of Dental Medicine and at Stanford University’s Genome Technology Center.
 
"A real need exists for point-of-care gene expression analysis, but without standardized measurements for expression patterns, current technology cannot produce reliable results,” said Gene Express’ executive VP of corporate development, David Lester, in a statement. 

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.